Alzheimer's disease is a condition that develops slowly and worsens with time. Alzheimer's disease eventually affects every part of your brain. The condition can affect memory, reasoning, judgement, language, problem-solving, personality, and movement. Preclinical Alzheimer's disease, mild cognitive impairment due to Alzheimer's disease, mild dementia due to Alzheimer's disease, moderate dementia due to Alzheimer's disease, moderate dementia due to Alzheimer's disease, and severe dementia due to Alzheimer's disease are the five stages of Alzheimer's disease. The five stages of Alzheimer's disease will help you comprehend what's happening.
Dementia is a group of disorders that cause memory loss and other mental processes to deteriorate. Dementia is a progressive disease that emerges as a result of physical changes in the brain. It is a condition that becomes worse with time. Dementia progresses rapidly for some people, while it takes years for others to reach an advanced state. Identifying the stage assists doctors in determining the appropriate treatments and facilitates communication between doctors and carers. Mild (or "early"), moderate (or "middle"), and severe (or "late") dementia are the three phases of dementia. However, symptoms are frequently used to designate a more specific stage of dementia.
- Preclinical Alzheimer's Disease
- Middle-Stage Alzheimer's
- Late-Stage Alzheimer's
- Mild Cognitive Impairment
- Mild Dementia Due to Alzheimer's Disease
- Moderate Dementia Due to Alzheimer's Disease
- Rate of Progression Through Alzheimer's
Yong-Xiao Wang
Albany Medical College, United States
Kaoru Sakatani
The University of Tokyo, Japan
Jun Hua
Johns Hopkins University School of Medicine, United StatesSubmit your abstract Today
Title : Evaluation of the neuroprotective potential of Indicaxanthin from Opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong-Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Diagnosis of alzheimer's disease using the effective communication of brain signals by granger causality method
Elias Mazrooei Rad, Khavaran Higher Education Institute, Iran (Islamic Republic of)
Title : Cognitive impairment resting-state fMRI markers in elderly
Karen Aguilar Mateu, Cuban Center for Neurosciences, Cuba